Abstract
Mitochondrial cytopathies constitute a group of rare diseases that are characterized by their frequent multisystemic involvement, extreme variability of phenotype and complex genetics. In children, renal involvement is frequent and probably underestimated. The most frequent renal symptom is a tubular defect that, in most severe forms, corresponds to a complete De Toni-Debré-Fanconi syndrome. Incomplete proximal tubular defects and other tubular diseases have also been reported. In rare cases, patients present with chronic tubulo-interstitial nephritis or cystic renal diseases. Finally, a group of patients develop primarily a glomerular disease. These patients correspond to sporadic case reports or can be classified into two major defects, namely 3243 A>G tRNALEU mutations and coenzyme Q10 biosynthesis defects. The latter group is particularly important because it represents the only treatable renal mitochondrial defect. In this Educational Review, the principal characteristics of these diseases and the main diagnostic approaches are summarized.
References
Finsterer J (2004) Mitochondriopathies. Eur J Neurol 11:163–186
Di Donato S (2009) Multisystem manifestations of mitochondrial disorders. J Neurol 256:693–710
DiMauro S, Schon EA (2003) Mitochondrial respiratory-chain diseases. N Engl J Med 348:2656–2668
Fosslien E (2001) Mitochondrial medicine - Molecular pathology of defective oxidative phosphorylation. Ann Clin Lab Sci 31:25–67
Quinzii CM, Hirano M (2010) Coenzyme Q and mitochondrial disease. Dev Disabil Res Rev 16:183–188
Casarin A, Jimenez-Ortega JC, Trevisson E, Pertegato V, Doimo M, Ferrero-Gomez ML, Abbadi S, Artuch R, Quinzii C, Hirano M, Basso G, Ocaña CS, Navas P, Salviati L (2008) Functional characterization of human COQ4, a gene required for Coenzyme Q10 biosynthesis. Biochem Biophys Res Commun 372:35–39
Artuch R, Salviati L, Jackson S, Hirano M, Navas P (2009) Coenzyme Q10 deficiencies in neuromuscular diseases. Adv Exp Med Biol 652:117–128
Zeviani M, Carelli V (2007) Mitochondrial disorders. Curr Opin Neurol 20:564–571
DiMauro S, Schon EA (2008) Mitochondrial disorders in the nervous system. Annu Rev Neurosci 31:91–123
Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM, Elsas LJ, Nikoskelainen EK (1988) Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science 242:1427–1430
Holt IJ, Harding AE, Morgan Hughes JA (1988) Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331:717–719
McFarland R, Taylor RW, Turnbull DM (2007) Mitochondrial disease - its impact, etiology, and pathology. Curr Top Dev Biol 77:113–155
Bertini E (2009) Mitochondrial encephalomyopathies and related syndromes: brief review. In: Cappa M, Maghnie M, Loche S and Bottazzo GF (eds) Endocrine involvement in developmental syndromes. Endocr Dev Basel, Karger 14:38–52
Moraes CT, Shanske S, Tritschler HJ, Aprille JR, Andreetta F, Bonilla E, Schon EA, DiMauro S (1991) mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 48:492–501
Kopsidas G, Kovalenko SA, Heffernan DR, Yarovaya N, Kramarova L, Stojanovski D, Borg J, Islam MM, Caragounis A, Linnane AW (2000) Tissue mitochondrial DNA changes. A stochastic system. Ann NY Acad Sci 908:226–243
von Kleist-Retzow JC, Cormier-Daire V, Viot G, Goldenberg A, Mardach B, Amiel J, Saada P, Dumez Y, Brunelle F, Saudubray JM, Chrétien D, Rötig A, Rustin P, Munnich A, De Lonlay P (2003) Antenatal manifestations of mitochondrial respiratory chain deficiency. J Pediatr 143:208–212
Bodemer C, Rötig A, Rustin P, Cormier V, Niaudet P, Saudubray JM, Rabier D, Munnich A, de Prost Y (1999) Hair and skin disorders as signs of mitochondrial disease. Pediatrics 103:428–433
Niaudet P, Rotig A (1997) The kidney in mitochondrial cytopathies. Kidney Int 51:1000–1007
Ogasahara S, Engel AG, Frens D, Mack D (1989) Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci USA 86:2379–2382
Montero R, Sánchez-Alcázar JA, Briones P, Hernández AR, Cordero MD, Trevisson E, Salviati L, Pineda M, García-Cazorla A, Navas P, Artuch R (2008) Analysis of coenzyme Q10 in muscle and fibroblasts for the diagnosis of CoQ10 deficiency syndromes. Clin Biochem 41:697–700
López-Martín JM, Salviati L, Trevisson E, Montini G, DiMauro S, Quinzii C, Hirano M, Rodriguez-Hernandez A, Cordero MD, Sánchez-Alcázar JA, Santos-Ocaña C, Navas P (2007) Missense mutation of the COQ2 gene causes defects of bioenergetics and de novo pyrimidine synthesis. Hum Mol Genet 16:1091–1097
Cordero MD, Moreno-Fernández AM, deMiguel M, Bonal P, Campa F, Jiménez-Jiménez LM, Ruiz-Losada A, Sánchez-Domínguez B, Sánchez Alcázar JA, Salviati L, Navas P (2009) Coenzyme Q10 distribution in blood is altered in patients with fibromyalgia. Clin Biochem 42:732–735
Kirby DM, Thorburn DR, Turnbull DM, Taylor RW (2007) Biochemical assays of respiratory chain complex activity. Meth Cell Biol 80:93–119
Chretien D, Rustin P, Bourgeron T, Rötig A, Saudubray JM, Munnich A (1994) Reference charts for respiratory chain activities in human tissues. Clin Chim Acta 228:53–70
Diomedi-Camassei F, Di Giandomenico S, Santorelli FM, Caridi G, Piemonte F, Montini G, Ghiggeri GM, Murer L, Barisoni L, Pastore A, Muda AO, Valente ML, Bertini E, Emma F (2007) COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J Am Soc Nephrol 18:2773–2780
Mita S, Schmidt B, Schon EA, DiMauro S, Bonilla E (1989) Detection of “deleted” mitochondrial genomes in cytochromeoxidase-deficient muscle fibers of a patient with Kearns–Sayre syndrome. Proc Natl Acad Sci USA 86:9509–9513
Santorelli FM, Sciacco M, Tanji K, Shanske S, Vu TH, Golzi V, Griggs RC, Mendell JR, Hays AP, Bertorini TE, Pestronk A, Bonilla E, DiMauro S (1996) Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients. Ann Neurol 39:789–795
Szabolcs MJ, Seigle R, Shanske S, Bonilla E, DiMauro S, D’Agati V (1994) Mitochondrial DNA deletion: a cause of chronic tubulointerstitial nephropathy. Kidney Int 45:1388–1396
Emma F, Pizzini C, Tessa A, Di Giandomenico S, Onetti-Muda A, Santorelli FM, Bertini E, Rizzoni G (2006) “Bartter-like” phenotype in Kearns–Sayre syndrome. Pediatr Nephrol 21:355–360
DiMauro S, Haller RG (1999) Metabolic myopathies: substrate use defects; in Schapira AHV, Griggs RC (eds): Muscle Diseases. Boston, Butterworth-Heinernann, pp 225–249
Au KM, Lau SC, Mak YF, Lai WM, Chow TC, Chen ML, Chiu MC, Chan AY (2007) Mitochondrial DNA deletion in a girl with Fanconi's syndrome. Pediatr Nephrol 22:136–140
Kuwertz-Bröking E, Koch HG, Marquardt T, Rossi R, Helmchen U, Müller-Höcker J, Harms E, Bulla M (2000) Renal Fanconi syndrome: first sign of partial respiratory chain complex IV deficiency. Pediatr Nephrol 14:495–498
Mochizuki H, Joh K, Kawame H, Imadachi A, Nozaki H, Ohashi T, Usui N, Eto Y, Kanetsuna Y, Aizawa S (1996) Mitochondrial encephalomyopathies preceded by de-Toni-Debré-Fanconi syndrome or focal segmental glomerulosclerosis. Clin Nephrol 46:347–352
Gilbert RD, Emms M (1996) Pearson's syndrome presenting with Fanconi syndrome. Ultrastruct Pathol 20:473–475
Martin-Hernandez E, Garcia-Silva MT, Vara J, Campos Y, Cabello A, Muley R, del Hoyo P, Angel Martin M, Arenas J (2005) Renal pathology in children with mitochondrial diseases. Pediatr Nephrol 20:1299–1305
De Meirleir L, Seneca S, Damis E, Sepulchre B, Hoorens A, Gerlo E, García Silva MT, Hernandez EM, Lissens W, Van Coster R (2003) Clinical and diagnostic characteristics of complex III deficiency due to mutations in the BCS1L gene. Am J Med Genet A 121A:126–131
Matsutani H, Mizusawa Y, Shimoda M, Niimura F, Takeda A, Shimohira M, Iwakawa Y (1992) Partial deficiency of cytochrome c oxidase with isolated proximal renal tubular acidosis and hypercalciuria. Child Nephrol Urol 12:221–224
Eviatar l, Shanskee S, Gauthier B, Abrams C, Mayral J, Slavin M, Valderrama E, DiMauro S (1990) Kearns-Sayre syndrome presenting as renal tubular acidosis. Neurology 40:1761–1763
Goto Y, Itami N, Kajii N, Tochimaru H, Endo M, Horai S (1990) Renal tubular involvement mimicking Bartter syndrome in a patient with Kearns–Sayre syndrome. J Pediatr 116:904–910
Katsanos KH, Elisaf M, Bairaktari E, Tsianos EV (2001) Severe hypomagnesemia and hypoparathyroidism in Kearns-Sayre syndrome. Am J Nephrol 21:150–153
Ueda Y, Ando A, Nagata T, Yanagida H, Yagi K, Sugimoto K, Okada M, Takemura T (2004) A boy with mitochondrial disease: asymptomatic proteinuria without neuromyopathy. Pediatr Nephrol 19:107–110
Tzen CY, Tsai JD, Wu TY, Chen BF, Chen ML, Lin SP, Chen SC (2001) Tubulointerstitial nephritis associated with a novel mitochondrial point mutation. Kidney Int 59:846–854
Rötig A, Goutières F, Niaudet P, Rustin P, Chretien D, Guest G, Mikol J, Gubler MC, Munnich A (1995) Deletion of mitochondrial DNA in patient with chronic tubulointerstitial nephritis. J Pediatr 126:597–601
Hameed R, Raafat F, Ramani P, Gray G, Roper HP, Milford DV (2001) Mitochondrial cytopathy presenting with focal segmental glomerulosclerosis, hypoparathyroidism, sensorineural deafness, and progressive neurological disease. Postgrad Med J 77:523–526
Gürgey A, Ozalp I, Rötig A, Coşkun T, Tekinalp G, Erdem G, Akeören Z, Caglar M, Bakkaloglu A (1996) A case of Pearson syndrome associated with multiple renal cysts. Pediatr Nephrol 10:637–638
Müller-Höcker J, Walther JU, Bise K, Pongratz D, Hübner G (1984) Mitochondrial myopathy with loosely coupled oxidative phosphorylation in a case of Zellweger syndrome. A cytochemical-ultrastructural study. Virchows Arch B Cell Pathol Incl Mol Pathol 45:125–138
Endo F, Sun MS (2002) Tyrosinaemia type I and apoptosis of hepatocytes and renal tubular cells. J Inherit Metab Dis 25:227–234
Nissim I, Horyn O, Daikhin Y, Nissim I, Luhovyy B, Phillips PC, Yudkoff M (2006) Ifosfamide-induced nephrotoxicity: mechanism and prevention. Cancer Res 66:7824–7831
Thévenod F (2003) Nephrotoxicity and the proximal tubule. Insights from cadmium. Nephron Physiol 93:87–93
Lino M, Binaut R, Noël LH, Patey N, Rustin P, Daniel L, Serpaggi J, Varaut A, Vanhille P, Knebelmann B, Grünfeld JP, Fakhouri F (2005) Tubulointerstitial nephritis and Fanconi syndrome in primary biliary cirrhosis. Am J Kidney Dis 46:41–46
Güçer S, Talim B, Aşan E, Korkusuz P, Ozen S, Unal S, Kalkanoğlu SH, Kale G, Cağlar M (2005) Focal segmental glomerulosclerosis associated with mitochondrial cytopathy: report of two cases with special emphasis on podocytes. Pediatr Dev Pathol 8:710–717
Unal S, Kalkanoğlu HS, Kocaefe C, Gucer S, Ozen S, Turanli G, Coskun T (2005) Four-month-old infant with focal segmental glomerulosclerosis and mitochondrial DNA deletion. J Child Neurol 20:83–84
Goldenberg A, Ngoc LH, Thouret MC, Cormier-Daire V, Gagnadoux MF, Chrétien D, Lefrançois C, Geromel V, Rötig A, Rustin P, Munnich A, Paquis V, Antignac C, Gubler MC, Niaudet P, de Lonlay P (2005) Bérard E (2005) Respiratory chain deficiency presenting as congenital nephrotic syndrome. Pediatr Nephrol 20:465–469
Guéry B, Choukroun G, Noël LH, Clavel P, Rötig A, Lebon S, Rustin P, Bellané-Chantelot C, Mougenot B, Grünfeld JP, Chauveau D (2003) The spectrum of systemic involvement in adults presenting with renal lesion and mitochondrial tRNA(Leu) gene mutation. J Am Soc Nephrol 14:2099–2108
Jansen JJ, Maassen JA, van der Woude FJ, Lemmink HA, van den Ouweland JM, t' Hart LM, Smeets HJ, Bruijn JA, Lemkes HH (1997) Mutation in mitochondrial tRNA (Leu(UUR)) gene associated with progressive kidney disease. J Am Soc Nephrol 8:1118–1124
Moulonguet Doleris L, Hill GS, Chedin P, Nochy D, Bellanne-Chantelot C, Hanslik T, Bedrossian J, Caillat-Zucman S, Cahen-Varsaux J, Bariety J (2000) Focal segmental glomerulosclerosis associated with mitochondrial cytopathy. Kidney Int 58:1851–1858
Löwik MM, Hol FA, Steenbergen EJ, Wetzels JF, van den Heuvel LP (2005) Mitochondrial tRNALeu(UUR) mutation in a patient with steroid-resistant nephrotic syndrome and focal segmental glomerulosclerosis. Nephrol Dial Transplant 20:336–341
Hotta O, Inoue CN, Miyabayashi S, Furuta T, Takeuchi A, Taguma Y (2001) Clinical and pathologic features of focal segmental glomerulosclerosis with mitochondrial tRNALeu(UUR) gene mutation. Kidney Int 59:1236–1243
Cheong HI, Chae JH, Kim JS, Park HW, Ha IS, Hwang YS, Lee HS, Choi Y (1999) Hereditary glomerulopathy associated with a mitochondrial tRNA(Leu) gene mutation. Pediatr Nephrol 13:477–480
Kurogouchi F, Oguchi T, Mawatari E, Yamaura S, Hora K, Takei M, Sekijima Y, Ikeda S, Kiyosawa K (1998) A case of mitochondrial cytopathy with a typical point mutation for MELAS, presenting with severe focal-segmental glomerulosclerosis as main clinical manifestation. Am J Nephrol 18:551–556
Nakamura S, Yoshinari M, Doi Y, Yoshizumi H, Katafuchi R, Yokomizo Y, Nishiyama K, Wakisaka M, Fujishima M (1999) Renal complications in patients with diabetes mellitus associated with an A to G mutation of mitochondrial DNA at the 3243 position of leucine tRNA. Diab Res Clin Pract 44:183–189
Hirano M, Konishi K, Arata N, Iyori M, Saruta T, Kuramochi S, Akizuki M (2002) Renal complications in a patient with A-to-G mutation of mitochondrial DNA at the 3243 position of leucine tRNA. Intern Med 41:113–118
Musumeci O, Naini A, Slonim AE, Skavin N, Hadjigeorgiou GL, Krawiecki N, Weissman BM, Tsao CY, Mendell JR, Shanske S, De Vivo DC, Hirano M, DiMauro S (2001) Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology 56:849–855
Rötig A, Appelkvist EL, Geromel V, Chretien D, Kadhom N, Edery P, Lebideau M, Dallner G, Munnich A, Ernster L, Rustin P (2000) Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 356:391–395
Salviati L, Sacconi S, Murer L, Zacchello G, Franceschini L, Laverda AM, Basso G, Quinzii C, Angelini C, Hirano M, Naini AB, Navas P, DiMauro S, Montini G (2005) Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition. Neurology 65:606–608
Montini G, Malaventura C, Salviati L (2008) Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N Engl J Med 358:2849–2850
Quinzii C, Naini A, Salviati L, Trevisson E, Navas P, Dimauro S, Hirano M (2006) A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am J Hum Genet 78:345–349
Forsgren M, Attersand A, Lake S, Grünler J, Swiezewska E, Dallner G, Climent I (2004) Isolation and functional expression of human COQ2, a gene encoding a polyprenyl transferase involved in the synthesis of CoQ. Biochem J 382:519–526
Mollet J, Giurgea I, Schlemmer D, Dallner G, Chretien D, Delahodde A, Bacq D, de Lonlay P, Munnich A, Rötig A (2007) Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. J Clin Invest 117:765–772
López LC, Schuelke M, Quinzii CM, Kanki T, Rodenburg RJ, Naini A, Dimauro S, Hirano M (2006) Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am J Hum Genet 79:1125–1129
Heeringa SF, Chernin g, Chaki M, Zhou W, Sloan AJ, Ji Z, Xie LX, Salviati L, Hurd TW, Vega-Warner V, Killen PD, Raphael Y, Ashraf S, Ovunc B, Schoeb DS, mcLaughlin HM, Airik R, Vlangos CL, Gbadegesin R, Hinkes B, Saisawat P, Trevisson E, Doimo M, Casarin A, Pertegato V, Giorgi G, Prokisch H, Rötig A, Antignac C, Nurnberg G, Beker C, Wang S, Ozaltin F, Topaloglu R, Bakkaloglu A, Bakkaloglu SA, Müller D, Beissert A, Mir S, Berdeli A, Özen S, Zenker M, Matejas V, Ocana CS, Navas P, Kusakabe T, Kispert A, Akman S, Soliman NA, Krick S, Mundel P, Reiser J, Nurnberg P, Clarke Cf, Wiggins RC, Faul C, Hildebrandt F (2011) COQ6 mutations cause nephrotic syndrome with sensorineural deafness in humans, concurrent with increased apoptosis. J Clin Invest 121:2013–2024
Duncan AJ, Bitner-Glindzicz M, Meunier B, Costello H, Hargreaves IP, López LC, Hirano M, Quinzii CM, Sadowski MI, Hardy J, Singleton A, Clayton PT, Rahman S (2009) A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease. Am J Hum Genet 84:558–566
Lagier-Tourenne C, Tazir M, López LC, Quinzii CM, Assoum M, Drouot N, Busso C, Makri S, Ali-Pacha L, Benhassine T, Anheim M, Lynch DR, Thibault C, Plewniak F, Bianchetti L, Tranchant C, Poch O, DiMauro S, Mandel JL, Barros MH, Hirano M, Koenig M (2008) ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. Am J Hum Genet 82:661–672
Mollet J, Delahodde A, Serre V, Chretien D, Schlemmer D, Lombes A, Boddaert N, Desguerre I, de Lonlay P, de Baulny HO, Munnich A, Rötig A (2008) CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am J Hum Genet 82:623–630
Barisoni L, Madaio MP, Eraso M, Gasser DL, Nelson PJ (2005) The kd/kd mouse is a model of collapsing glomerulopathy. J Am Soc Nephrol 16:2847–2851
López LC, Quinzii CM, Area E, Naini A, Rahman S, Schuelke M, Salviati L, Dimauro S, Hirano M (2010) Treatment of CoQ(10) deficient fibroblasts with ubiquinone, CoQ analogs, and vitamin C: time- and compound-dependent effects. PLoS ONE 5:e11897
Land JM, Heales SJ, Duncan AJ, Hargreaves IP (2007) Some observations upon biochemical causes of ataxia and a new disease entity ubiquinone, CoQ10 deficiency. Neurochem Res 32:837–843
Hatanaka J, Kimura Y, Lai-Fu Z, Onoue S, Yamada S (2008) Physicochemical and pharmacokinetic characterization of water-soluble Coenzyme Q(10) formulations. Int J Pharm 363:112–117
Peng M, Falk MJ, Haase VH, King R, Polyak E, Selak M, Yudkoff M, Hancock WW, Meade R, Saiki R, Lunceford AL, Clarke CF, Gasser DL (2008) Primary coenzyme Q deficiency in Pdss2 mutant mice causes isolated renal disease. PLoS Genet 4:e1000061
Open Access
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Author information
Authors and Affiliations
Corresponding author
Additional information
Answers:
1. E
2. A
3. C
4. E
5. E
Rights and permissions
About this article
Cite this article
Emma, F., Bertini, E., Salviati, L. et al. Renal involvement in mitochondrial cytopathies. Pediatr Nephrol 27, 539–550 (2012). https://doi.org/10.1007/s00467-011-1926-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-011-1926-6